Med Page Today
JUNE 20, 2024
(MedPage Today) -- Recently, a cardiologist published a commentary in Medscape arguing that physicians and scientists who challenge the putative clinical benefit of statin medications are pseudoscientists. He claimed, ".somewhere along the way.
Dr. Smith's ECG Blog
JUNE 17, 2024
Written by Bobby Nicholson, MD 67 year old male with history of hypertension and hyperlipidemia presented to the Emergency Department via ambulance with midsternal nonradiating chest pain and dyspnea on exertion. Pain improved to 1/10 after EMS administers 324 mg aspirin and the following EKG is obtained at triage. What do you think? If this EKG were handed to you to screen from triage without any clinical information, what would you think?
HCPLive
JUNE 18, 2024
The approval is based on data from a pair of phase 3 studies and makes risankizumab-rzaa the first IL-23 specific inhibitor approved for both ulcerative colitis and Crohn’s disease.
DAIC
JUNE 19, 2024
Eugenio Cingolani, MD. Photo by Cedars-Sinai. milla1cf Wed, 06/19/2024 - 20:57 June 19, 2024 — When electrophysiologist Eugenio Cingolani, MD , isn’t seeing patients, he can usually be found in his laboratory, investigating improved treatments for heart rhythm disorders. Cingolani, director of Cardiogenetics and Preclinical Research in the Department of Cardiology in the Smidt Heart Institute at Cedars-Sinai, is exploring new ways to help patients with ventricular tachycardia (VT), a recurrin
Medical Xpress - Cardiology
JUNE 18, 2024
The over-the-counter supplement nicotinamide riboside, a form of vitamin B3, increased the walking endurance of patients with peripheral artery disease, a chronic leg condition for which there are few effective treatments.
Science Daily - Heart Disease
JUNE 19, 2024
Women diagnosed with perinatal depression are more likely to develop cardiovascular disease in the following 20 years compared to women who have given birth without experiencing perinatal depression. The study is the first of its kind to look at cardiovascular health after perinatal depression and included data on around 600,000 women. It found the strongest links with risks of high blood pressure, ischemic heart disease and heart failure.
Med Page Today
JUNE 21, 2024
(MedPage Today) -- As temperatures and humidity soar outside, what's happening inside the human body can become a life-or-death battle decided by just a few degrees. The critical danger point outdoors for illness and death from relentless heat.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
Cardiovascular Diabetology
JUNE 18, 2024
To evaluate the association between diabetic foot disease (DFD) and the incidence of fatal and non-fatal events in individuals with type 2 diabetes (T2DM) from primary-care settings.
DAIC
JUNE 19, 2024
Getty Images milla1cf Wed, 06/19/2024 - 20:54 June 19, 2024 — Modern therapies have extended the lives of many cancer patients; however, survivors often live with chronic health conditions, including cardiovascular disease. New research published in JACC: CardioOncology shows that air pollution plays a significant role in increasing cardiovascular disease and mortality in cancer patients and contributes to health disparities related to these conditions.
Med Page Today
JUNE 21, 2024
(MedPage Today) -- ORLANDO -- Technologic advances aren't fulfilling their promise for improving diabetes or overall health outcomes in the U.S., argued FDA Commissioner Robert Califf, MD. "We are wowing the world in technology -- much of.
ECG Cases
JUNE 18, 2024
Dr. Jesse McLaren illustrates the paradigm shift from STEMI to Occlusion MI (OMI) through 9 cases, and drives home the points that if there is STEMI criteria, consider false positives (eg. secondary and proportional to LVH or BER); if there is no STEMI criteria, consider false negatives and look for other signs of occlusion (eg. acute Q waves or loss of R waves, hyperacute T waves, or reciprocal STD/TWI) and if the ECG is nondiagnostic, consider other OMI signs including clinical (refractory isc
Science Daily - Heart Disease
JUNE 21, 2024
While previous studies suggested an association of the most common cerebral small-vessel disease with dementia risk, new research provides evidence of causal link, identifying it as a major vascular factor.
DAIC
JUNE 18, 2024
Getty Images milla1cf Tue, 06/18/2024 - 19:56 June 18, 2024 — As we commemorate Juneteenth 2024, JACC , the flagship journal of the American College of Cardiology , has published “Excess Cardiovascular Mortality Among Black Americans 2000-2022: A Report Card,” to highlight the persistent and tragic inequities in cardiovascular care and put in human terms the years of life lost to the Black community because of their higher cardiovascular disease death rates.
Med Page Today
JUNE 20, 2024
(MedPage Today) -- People with systemic lupus erythematosus (SLE) had lower rates of lupus nephritis, chronic kidney disease, and other complications when they were taking metformin, an analysis of medical records indicated. Among some 88,000.
American Heart News - Heart News
JUNE 20, 2024
DALLAS, June 20, 2024 — It’s only the first day of summer and record high temperatures are already being reported across much of the U.S. That’s prompted the American Heart Association, celebrating a century of lifesaving service as the world’s leading.
Medical Xpress - Cardiology
JUNE 17, 2024
Generative Artificial Intelligence (Gen AI) can rapidly and accurately screen patients for clinical trial eligibility, according to a new study from Mass General Brigham researchers. Such technology could make it faster and cheaper to evaluate new treatments and, ultimately, help bring successful ones to patients.
DAIC
JUNE 21, 2024
milla1cf Fri, 06/21/2024 - 20:10 June 21, 2024 — UC San Francisco interventional cardiologists and interventional echocardiographers recently performed the health system’s first commercial transcatheter tricuspid valve replacement procedure using the Edwards EVOQUE system. The novel and minimally invasive cardiac procedure was recently approved for use within the U.S. by the Food and Drug Administration.
Med Page Today
JUNE 17, 2024
(MedPage Today) -- There was a steady increase in the prevalence of chronic hypertension in pregnancy over the last two decades, with some accompanying changes in treatment, a nationwide cohort study found. From 2008 to 2021, the prevalence of.
HCPLive
JUNE 17, 2024
Patients with psoriasis on biological agents might have a lower PsA risk than those on methotrexate, but patients on topical therapy have an even lower risk, a study found.
Medical Xpress - Cardiology
JUNE 17, 2024
A new smartphone face-screening tool could help paramedics to identify stroke in seconds—much sooner and more accurately than is possible with current technologies.
DAIC
JUNE 20, 2024
milla1cf Thu, 06/20/2024 - 19:42 June 20, 2024 — Microbot Medical Inc. announced its agreement with Brigham and Women’s Hospital ( BWH ), a leading academic medical center located in Boston, Massachusetts, to serve as one of the sites to perform the pivotal human clinical trial for its LIBERTY Endovascular Robotic Surgical System , as part of its Investigational Device Exemption (“IDE”) application.
Med Page Today
JUNE 18, 2024
(MedPage Today) -- Women with perinatal depression (PND) had a higher risk of cardiovascular disease (CVD) in middle adulthood than matched parous women without PND, a Swedish nationwide study found. Over a mean of 10.4 years, women with PND had.
Science Daily - Stroke
JUNE 18, 2024
The over-the-counter supplement nicotinamide riboside, a form of vitamin B3, increased the walking endurance of patients with peripheral artery disease, a chronic leg condition for which there are few effective treatments.
Medical Xpress - Cardiology
JUNE 17, 2024
A team of researchers led by Monash University and the Baker Heart and Diabetes Institute have published the first compelling evidence of the therapeutic potential of a new therapy to treat hypertension-induced organ damage. The paper appears in the journal Cardiovascular Research.
DAIC
JUNE 20, 2024
The reSept ASD Occluder has a bioresorbable, metal-free frame milla1cf Thu, 06/20/2024 - 19:39 June 20, 2024 — atHeart Medical , a medical device company establishing a new standard of care for atrial septal defects (ASDs) closure, announced promising long and short-term clinical outcomes of its reSept ASD occluder , to be presented at the medical conference CSI Frankfurt.
HCPLive
JUNE 21, 2024
A first-time trial presented at ADA 2024 found the common cholesterol-lowering drug halts vision loss in patients with diabetic eye disease.
JAMA Cardiology
JUNE 17, 2024
This randomized clinical trial investigates the effectiveness and safety of a nonphysician-led, multifaceted, intensive blood pressure intervention in younger and older individuals with hypertension.
Circulation
JUNE 20, 2024
Circulation, Ahead of Print. There is significant variability in the efficacy and safety of oral P2Y12 inhibitors, which are used to prevent ischemic outcomes in common diseases such as coronary and peripheral arterial disease and stroke. Clopidogrel, a prodrug, is the most used oral P2Y12 inhibitor and is activated primarily after being metabolized by a highly polymorphic hepatic cytochrome CYP2C219 enzyme.
DAIC
JUNE 20, 2024
milla1cf Thu, 06/20/2024 - 19:40 June 20, 2024 — A programing algorithm, being tested by HonorHealth Research Institute for those patients with new or recently installed pacemakers, is designed so the device not only provides a steady heartbeat, but also controls high blood pressure. A recently opened clinical trial called BACKBEAT (BradycArdia paCemaKer for Blood prEssure treAtmenT) aims to use Medtronic’s Astra and Azure model pacemakers to not only treat slow heart rates but also delivers
HCPLive
JUNE 18, 2024
Findings suggest machine learning models may have promising utility in IgAN, highlighting the superior diagnostic performance of certain models versus standard logistic regression.
Journal of Clinical Investigation - Cardiology
JUNE 17, 2024
Cancer cells exhibit heightened secretory states that drive tumor progression. Here, we identified a chromosome 3q amplicon that serves as a platform for secretory regulation in cancer. The 3q amplicon encodes multiple Golgi-resident proteins, including the scaffold Golgi integral membrane protein 4 (GOLIM4) and the ion channel ATPase secretory pathway Ca2+ transporting 1 (ATP2C1).
Cardiology Update
JUNE 16, 2024
Coronary artery disease remains a leading cause of morbidity and mortality worldwide. Recent research has illuminated the role of total coronary atherosclerotic plaque activity across the entire coronary arterial tree in predicting patient-level clinical outcomes. However, the association between vessel-level coronary atherosclerotic plaque activity and the incidence of vessel-level myocardial infarction (MI) has not been fully explored.
DAIC
JUNE 20, 2024
A new report from AMN Healthcare finds that allied health professionals, such as radiology technologists and therapists, can generate millions of dollars a year for their facilities. The company’s “2024 Allied Healthcare Professional Revenue and ROI Report” tracks net revenue generated by various types of radiology technologists and therapists, less the cost of staffing them on a contingent basis.
HCPLive
JUNE 16, 2024
Karen Costenbader, MD, discusses the 2 post hoc analyses that demonstrated treatment with belimumab reduces flares and increases response rates among patients with early active SLE.
Heart Sisters
JUNE 16, 2024
This study looked at what gardeners already suspect: "Gardening is associated with better cardiovascular health among older adults compared to older adults who do not garden"
Med Page Today
JUNE 21, 2024
(MedPage Today) -- As an adjunct to bypass surgery for ischemic cardiomyopathy, a cardiac shockwave therapy aimed at regenerating ischemic myocardium boosted left ventricular ejection fraction (LVEF) and physical function at 1 year in a small sham.
DAIC
JUNE 19, 2024
milla1cf Wed, 06/19/2024 - 20:50 June 19, 2024 — Stereotaxis , a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has received CE Mark recertification under the European Union’s new Medical Device Regulation (MDR) regulatory framework. The recertification under MDR covers all Stereotaxis devices currently available in Europe.
Expert insights. Personalized for you.
140 
Let's personalize your content